Literature DB >> 15061289

The human perspective on health care reform: coping with diabetes in Kyrgyzstan.

Botagoz Hopkinson1, Dina Balabanova, Martin McKee, Joseph Kutzin.   

Abstract

Health systems world wide are confronted by the challenge of rising levels of chronic diseases. Yet existing approaches to health system analysis often fail to capture the complexity of the responses required to address this challenge. In this paper we describe the results of a pilot study using a rapid appraisal technique to assess the performance of the health care system in Kyrgyzstan, a former Soviet central Asian republic. The study focuses on diabetes, a condition whose effective management requires a coordinated response involving many components of the health care system. The study sets out a conceptual framework in which the system is seen from the perspectives of users, health professionals and policy-makers. It sees the effective delivery of health care as dependent on appropriate investment in human, physical, intellectual and social resources. The study reveals important weaknesses in all of these areas, although it also notes that current policies, while constrained by the legacy of the past and by limited resources, are beginning to tackle them. This pilot study indicates that rapid appraisal, using a condition such as diabetes, where those affected can be easily identified, offers a means of gaining important insights into a health care system.

Entities:  

Mesh:

Year:  2004        PMID: 15061289     DOI: 10.1002/hpm.745

Source DB:  PubMed          Journal:  Int J Health Plann Manage        ISSN: 0749-6753


  8 in total

1.  Health service utilization in the former soviet union: evidence from eight countries.

Authors:  Dina Balabanova; Martin McKee; Joceline Pomerleau; Richard Rose; Christian Haerpfer
Journal:  Health Serv Res       Date:  2004-12       Impact factor: 3.402

2.  Prescription for change: accessing medication in transitional Russia.

Authors:  Francesca Perlman; Dina Balabanova
Journal:  Health Policy Plan       Date:  2011-01-02       Impact factor: 3.547

3.  Assessing health systems for type 1 diabetes in sub-Saharan Africa: developing a 'Rapid Assessment Protocol for Insulin Access'.

Authors:  David Beran; John S Yudkin; Maximilian de Courten
Journal:  BMC Health Serv Res       Date:  2006-02-24       Impact factor: 2.655

4.  Understanding the modifiable health systems barriers to hypertension management in Malaysia: a multi-method health systems appraisal approach.

Authors:  Isabelle Risso-Gill; Dina Balabanova; Fadhlina Majid; Kien Keat Ng; Khalid Yusoff; Feisul Mustapha; Charlotte Kuhlbrandt; Robby Nieuwlaat; J-D Schwalm; Tara McCready; Koon K Teo; Salim Yusuf; Martin McKee
Journal:  BMC Health Serv Res       Date:  2015-07-03       Impact factor: 2.655

Review 5.  Assessing the influence of health systems on Type 2 Diabetes Mellitus awareness, treatment, adherence, and control: A systematic review.

Authors:  Suan Ee Ong; Joel Jun Kai Koh; Sue-Anne Ee Shiow Toh; Kee Seng Chia; Dina Balabanova; Martin McKee; Pablo Perel; Helena Legido-Quigley
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

6.  An analysis of trends and determinants of health insurance and healthcare utilisation in the Russian population between 2000 and 2004: the 'inverse care law' in action.

Authors:  Francesca Perlman; Dina Balabanova; Martin McKee
Journal:  BMC Health Serv Res       Date:  2009-04-27       Impact factor: 2.655

7.  SUPPORT tools for evidence-informed policymaking in health 11: Finding and using evidence about local conditions.

Authors:  Simon Lewin; Andrew D Oxman; John N Lavis; Atle Fretheim; Sebastian Garcia Marti; Susan Munabi-Babigumira
Journal:  Health Res Policy Syst       Date:  2009-12-16

Review 8.  The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review.

Authors:  Will Maimaris; Jared Paty; Pablo Perel; Helena Legido-Quigley; Dina Balabanova; Robby Nieuwlaat; Martin McKee
Journal:  PLoS Med       Date:  2013-07-30       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.